SciDEX — neurodegenerative

Understanding Entity Pages

This page aggregates everything SciDEX knows about neurodegenerative_diseases: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

Outgoing (0)

Target	Relation	Type	Str
No outgoing edges

Incoming (23)

Source	Relation	Type	Str
SQSTM1	implicated_in	gene	0.80
APAF1	implicated_in	protein	0.70
sporadic-familial-pd-comparison	type_of	disease	0.30
Caregiver Burden and Support in Corticobasal Syndrome	type_of	disease	0.30
Lysosomal Enzyme Dysfunction Across Neurodegenerative Diseases	type_of	disease	0.30
Somatosensory Deficits in Corticobasal Syndrome	type_of	disease	0.30
Sporadic vs Familial Alzheimer's Disease: Comprehensive Comparison	type_of	disease	0.30
Visuospatial Dysfunction in Corticobasal Syndrome	type_of	disease	0.30
Vocational Rehabilitation and Driving in Corticobasal Syndrome	type_of	disease	0.30
mitochondrial-dysfunction-neurodegeneration-comparison	type_of	disease	0.30
Botulinum Toxin Therapy in Corticobasal Syndrome	type_of	disease	0.30
Clinical Phenotypes and Subtypes of Corticobasal Syndrome	type_of	disease	0.30
Executive Dysfunction in Corticobasal Syndrome	type_of	disease	0.30
Functional Network Connectivity in Corticobasal Syndrome	type_of	disease	0.30
Quantitative MRI in Corticobasal Syndrome	type_of	disease	0.30
cerebral-metabolism-perfusion-cbs	type_of	disease	0.30
Attention Dysfunction in Corticobasal Syndrome	type_of	disease	0.30
Cholinergic Dysfunction in Corticobasal Syndrome	type_of	disease	0.30

Hypothesis	Score	Disease	Analysis
No targeting hypotheses

Hypothesis

Score

Disease

Analysis

No targeting hypotheses

Mentioning Analyses (12)

Scientific analyses that reference this entity

What are the precise temporal dynamics of astrocyte ketone production decline du

neurodegeneration | 2026-04-15 | 2 hypotheses Top: 0.645

What molecular mechanisms cause iPLA2β deficiency to specifically damage mitocho

neurodegeneration | 2026-04-15 | 0 hypotheses

Why does autophagy inhibition improve neuronal survival when autophagy is typica

neurodegeneration | 2026-04-15 | 1 hypotheses Top: 0.557

What molecular mechanisms determine whether reactive astrocytes adopt neurotoxic

neuroinflammation | 2026-04-14 | 2 hypotheses Top: 0.596

How does TRIM21-mediated K63 ubiquitination of G3BP1 mechanistically inhibit liq

neurodegeneration | 2026-04-07 | 0 hypotheses

Experiment	Type	Disease	Score	Feasibility	Model	Status	Est. Cost
No experiments found

Experiment

Type

Disease

Score

Feasibility

Model

Status

Est. Cost

No experiments found

Title & PMID	Authors	Journal	Year	Citations
No papers found

Title & PMID

Authors

Journal

Year

Citations

No papers found

neurodegenerative_diseases

Understanding Entity Pages

Wiki Pages (20)

cbs-psp-daily-action-plan

Personalized Treatment Plan — Atypical Parkinsonism (CBS/PSP)

AAV Gene Therapy for Neurodevelopmental Epilepsy — Competitive Landscape & Delivery Alternatives

Clinical Management Guide for CBS/PSP

Progressive Supranuclear Palsy (PSP)

Outgoing (0)

Incoming (23)

Targeting Hypotheses (0)

Mentioning Analyses (12)

What are the precise temporal dynamics of astrocyte ketone production decline du

What molecular mechanisms cause iPLA2β deficiency to specifically damage mitocho

Why does autophagy inhibition improve neuronal survival when autophagy is typica

What molecular mechanisms determine whether reactive astrocytes adopt neurotoxic

How does TRIM21-mediated K63 ubiquitination of G3BP1 mechanistically inhibit liq

Senescent cell clearance as neurodegeneration therapy

CRISPR-based therapeutic approaches for neurodegenerative diseases

CRISPR-based therapeutic approaches for neurodegenerative diseases

Metabolic reprogramming in neurodegenerative disease

Protein aggregation cross-seeding across neurodegenerative diseases

Autophagy-lysosome pathway convergence across neurodegenerative diseases

Protein aggregation cross-seeding across neurodegenerative diseases

Experiments (0)

Related Papers (0)

neurodegenerative_diseases

Understanding Entity Pages

Wiki Pages (20)

cbs-psp-daily-action-plan

Personalized Treatment Plan — Atypical Parkinsonism (CBS/PSP)

AAV Gene Therapy for Neurodevelopmental Epilepsy — Competitive Landscape & Delivery Alternatives

Clinical Management Guide for CBS/PSP

Progressive Supranuclear Palsy (PSP)

Corticobasal Syndrome (CBS)

Novel Therapy Index

Parkinson's Disease

Sleep and Circadian Dysfunction in Alzheimer's Disease

Microglia CD8+ T Cell Recruitment -- Supplementary WW Content

primary-progressive-aphasia

CBS/PSP Supplements Guide

Atypical Parkinsonism

Parthanatos in Neurodegeneration

CBS/PSP Rehabilitation Master Guide

calcium-dysregulation-comparison

Section 148: Advanced Nutritional Biochemistry in CBS/PSP

Alpha-Synuclein Pathology

PD Combination Therapy Matrix

Alzheimer's Disease Mechanism Index

Outgoing (0)

Incoming (23)

Targeting Hypotheses (0)

Mentioning Analyses (12)

What are the precise temporal dynamics of astrocyte ketone production decline du

What molecular mechanisms cause iPLA2β deficiency to specifically damage mitocho

Why does autophagy inhibition improve neuronal survival when autophagy is typica

What molecular mechanisms determine whether reactive astrocytes adopt neurotoxic

How does TRIM21-mediated K63 ubiquitination of G3BP1 mechanistically inhibit liq

Senescent cell clearance as neurodegeneration therapy

CRISPR-based therapeutic approaches for neurodegenerative diseases

CRISPR-based therapeutic approaches for neurodegenerative diseases

Metabolic reprogramming in neurodegenerative disease

Protein aggregation cross-seeding across neurodegenerative diseases

Autophagy-lysosome pathway convergence across neurodegenerative diseases

Protein aggregation cross-seeding across neurodegenerative diseases

Experiments (0)

Related Papers (0)